Fenofibrate/metformin - Solvay Pharmaceuticals
Alternative Names: Dualtis; LF 23-0121; SynordiaLatest Information Update: 13 Feb 2009
At a glance
- Originator Merck Sante
- Developer Solvay Pharmaceuticals
- Class Antihyperglycaemics; Antihyperlipidaemics; Biguanides; Fibric acid derivatives; Propionates
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Metabolic syndrome; Type 2 diabetes mellitus
Most Recent Events
- 30 Nov 2008 Discontinued - Phase-III for Metabolic syndrome in European Union (PO)
- 30 Nov 2008 Discontinued - Phase-III for Type-2 diabetes mellitus in European Union (PO)
- 08 Dec 2006 Phase-III for Metabolic syndrome in European Union (PO)